iRhythm price target raised to $165 from $140 at BTIG

BTIG analyst Marie Thibault raised the firm’s price target on iRhythm (IRTC) to $165 from $140 and keeps a Buy rating on the shares after the firm hosted investor meetings with its management team. The discussions focused on the company’s recent market share gains in the Zio AT segment, the competitive landscape, the asymptomatic opportunity with innovative channel partners, and remediation efforts regarding the warning letter and Form 483 observations, the analyst tells investors in a research note. The tone of these meetings was positive and the management was upbeat, remaining confident that the recent momentum can be sustained for the rest of the year and beyond, the firm added.